122 participants
Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-12
- Start Date:
- 2022-04-12
- Completion:
- 2024-04-08
Conditions
- Pulmonary TB
Interventions
- DRUG